TMEM244
gene geneOn this page
Also known as bA174C7.4
Summary
TMEM244 (transmembrane protein 244, HGNC:21571) is a protein-coding gene on chromosome 6q22.33, encoding Putative transmembrane protein 244 (Q5VVB8).
Predicted to be located in membrane.
Source: NCBI Gene 253582 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_001010876
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21571 |
| Approved symbol | TMEM244 |
| Name | transmembrane protein 244 |
| Location | 6q22.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA174C7.4 |
| Ensembl gene | ENSG00000203756 |
| Ensembl biotype | protein_coding |
| Entrez | 253582 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000368143, ENST00000438392, ENST00000850981
RefSeq mRNA: 1 — MANE Select: NM_001010876
NM_001010876
CCDS: CCDS34536
Canonical transcript exons
ENST00000368143 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001446410 | 129831244 | 129831386 |
| ENSE00001446411 | 129833460 | 129833585 |
| ENSE00001446412 | 129843530 | 129843603 |
| ENSE00001446413 | 129845767 | 129845852 |
| ENSE00001446415 | 129861156 | 129861315 |
Expression profiles
Bgee: expression breadth broad, 66 present calls, max score 84.46.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4665 / max 224.4485, expressed in 113 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 75516 | 0.1938 | 60 |
| 75514 | 0.1295 | 30 |
| 75517 | 0.1173 | 47 |
| 75515 | 0.0259 | 7 |
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.46 | gold quality |
| pituitary gland | UBERON:0000007 | 63.93 | gold quality |
| adenohypophysis | UBERON:0002196 | 59.34 | gold quality |
| granulocyte | CL:0000094 | 58.84 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 55.14 | gold quality |
| Ammon’s horn | UBERON:0001954 | 53.87 | gold quality |
| primary visual cortex | UBERON:0002436 | 52.46 | gold quality |
| substantia nigra | UBERON:0002038 | 51.21 | gold quality |
| amygdala | UBERON:0001876 | 50.88 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 50.82 | gold quality |
| temporal lobe | UBERON:0001871 | 50.56 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 50.46 | gold quality |
| corpus callosum | UBERON:0002336 | 50.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 48.59 | gold quality |
| lymph node | UBERON:0000029 | 48.56 | gold quality |
| cerebral cortex | UBERON:0000956 | 48.48 | gold quality |
| frontal cortex | UBERON:0001870 | 45.89 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 45.32 | gold quality |
| tonsil | UBERON:0002372 | 44.23 | gold quality |
| bone marrow cell | CL:0002092 | 42.15 | gold quality |
| brain | UBERON:0000955 | 41.67 | gold quality |
| right frontal lobe | UBERON:0002810 | 41.13 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.91 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow | UBERON:0002371 | 36.41 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| nucleus accumbens | UBERON:0001882 | 35.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.58 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sezary cells. (PMID:32794659)
- TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sezary Syndrome from Mycosis Fungoides and Benign Erythroderma. (PMID:36087622)
- TMEM244 Is a Long Non-Coding RNA Necessary for CTCL Cell Growth. (PMID:36834942)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem244 | ENSDARG00000043847 |
Paralogs (1): SYS1 (ENSG00000204070)
Protein
Protein identifiers
Putative transmembrane protein 244 — Q5VVB8 (reviewed: Q5VVB8)
All UniProt accessions (1): Q5VVB8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001010876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019185 | Integral_membrane_SYS1-rel | Family |
UniProt features (8 total): sequence variant 4, transmembrane region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VVB8-F1 | 84.51 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
chr6q22, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, TERF1_TARGET_GENES, HU_FETAL_RETINA_PHOTORECEPTOR, DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS, DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS, NKX2_5_TARGET_GENES, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP, GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN, GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
212 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM244 | TMEM141 | Q96I45 | 593 |
| TMEM244 | SMLR1 | H3BR10 | 574 |
| TMEM244 | PUSL1 | Q8N0Z8 | 559 |
| TMEM244 | C1orf115 | Q9H7X2 | 528 |
| TMEM244 | RASGEF1C | Q8N431 | 526 |
| TMEM244 | LYZL4 | Q96KX0 | 512 |
| TMEM244 | RSRC1 | Q96IZ7 | 504 |
| TMEM244 | SNAP47 | Q5SQN1 | 495 |
| TMEM244 | CENPBD1P | B2RD01 | 473 |
| TMEM244 | USF3 | Q68DE3 | 447 |
| TMEM244 | OR2AK2 | Q8NG84 | 447 |
| TMEM244 | CAAP1 | Q9H8G2 | 447 |
| TMEM244 | CAPN12 | Q6ZSI9 | 439 |
| TMEM244 | OR2L8 | Q8NGY9 | 430 |
| TMEM244 | KIF16B | Q96L93 | 418 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0N0DCA4, A0A194XK05, A0A7L9EZ67, A0A8F4NUZ8, A0A8F4S726, C6Y4A4, D2I2F3, G5EEQ9, O94440, P0DXW0, P32564, P34296, P53748, Q0VD15, Q10255, Q10436, Q12155, Q29RQ9, Q3B8H0, Q53FV1, Q55E32, Q5E972, Q5R570, Q5R8X5, Q5RFN8, Q5VVB8, Q5XH57, Q5XJR6, Q5ZIU0, Q6NZZ4, Q6QI25, Q6UX40, Q74ZU2, Q86H65, Q8JFB7, Q8N138, Q8STK5, Q8SW90, Q91VP7, Q921I0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1035 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:129845765:A:AC | donor_gain | 1.0000 |
| 6:129845766:C:CC | donor_gain | 1.0000 |
| 6:129833586:C:CC | acceptor_gain | 0.9900 |
| 6:129845766:CT:C | donor_gain | 0.9900 |
| 6:129861155:CCTTG:C | donor_gain | 0.9900 |
| 6:129833584:AACTG:A | acceptor_gain | 0.9800 |
| 6:129833585:ACTG:A | acceptor_gain | 0.9800 |
| 6:129833586:CTGC:C | acceptor_gain | 0.9800 |
| 6:129845758:GCTAC:G | donor_loss | 0.9800 |
| 6:129845759:CTACT:C | donor_loss | 0.9800 |
| 6:129845760:TAC:T | donor_loss | 0.9800 |
| 6:129845761:ACTTA:A | donor_loss | 0.9800 |
| 6:129845762:C:CA | donor_loss | 0.9800 |
| 6:129845763:T:TG | donor_loss | 0.9800 |
| 6:129845764:TACTC:T | donor_loss | 0.9800 |
| 6:129845765:ACTCA:A | donor_loss | 0.9800 |
| 6:129845766:C:CG | donor_loss | 0.9800 |
| 6:129861152:TTA:T | donor_loss | 0.9800 |
| 6:129861153:TACCT:T | donor_loss | 0.9800 |
| 6:129861154:ACCTT:A | donor_loss | 0.9800 |
| 6:129861155:C:CA | donor_loss | 0.9800 |
| 6:129833582:AGAAC:A | acceptor_gain | 0.9700 |
| 6:129833583:GAACT:G | acceptor_gain | 0.9700 |
| 6:129855079:AGG:A | donor_gain | 0.9600 |
| 6:129861156:C:G | donor_loss | 0.9600 |
| 6:129833583:GAA:G | acceptor_gain | 0.9500 |
| 6:129833587:T:A | acceptor_gain | 0.9500 |
| 6:129845757:TGCTA:T | donor_loss | 0.9500 |
| 6:129831387:C:CC | acceptor_gain | 0.9400 |
| 6:129833582:AGAA:A | acceptor_gain | 0.9400 |
AlphaMissense
820 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:129843573:A:C | F50L | 0.952 |
| 6:129843573:A:T | F50L | 0.952 |
| 6:129843575:A:G | F50L | 0.952 |
| 6:129843567:G:C | F52L | 0.950 |
| 6:129843567:G:T | F52L | 0.950 |
| 6:129843569:A:G | F52L | 0.950 |
| 6:129845814:G:C | F24L | 0.900 |
| 6:129845814:G:T | F24L | 0.900 |
| 6:129845816:A:G | F24L | 0.900 |
| 6:129831373:G:C | F111L | 0.873 |
| 6:129831373:G:T | F111L | 0.873 |
| 6:129831375:A:G | F111L | 0.873 |
| 6:129833511:A:G | W90R | 0.867 |
| 6:129833511:A:T | W90R | 0.867 |
| 6:129831354:A:G | W118R | 0.852 |
| 6:129831354:A:T | W118R | 0.852 |
| 6:129831357:A:G | W117R | 0.834 |
| 6:129831357:A:T | W117R | 0.834 |
| 6:129833509:C:A | W90C | 0.828 |
| 6:129833509:C:G | W90C | 0.828 |
| 6:129831352:C:A | W118C | 0.809 |
| 6:129831352:C:G | W118C | 0.809 |
| 6:129831355:C:A | W117C | 0.806 |
| 6:129831355:C:G | W117C | 0.806 |
| 6:129833536:A:C | F81L | 0.788 |
| 6:129833536:A:T | F81L | 0.788 |
| 6:129833538:A:G | F81L | 0.788 |
| 6:129831382:C:A | M108I | 0.783 |
| 6:129831382:C:G | M108I | 0.783 |
| 6:129831382:C:T | M108I | 0.783 |
dbSNP variants (sampled 300 via entrez): RS1000236427 (6:129852439 T>C), RS1000358891 (6:129847173 C>A,T), RS1000368616 (6:129846897 A>T), RS1000439853 (6:129836128 C>T), RS1000475266 (6:129841301 T>C), RS1000535042 (6:129841578 A>T), RS1000571524 (6:129831928 T>A,C), RS1000588668 (6:129852767 T>A), RS1000834754 (6:129853685 A>G), RS1001005614 (6:129831651 T>A), RS1001318091 (6:129838156 C>G), RS1001342162 (6:129863034 T>G), RS1001366578 (6:129862559 A>C,G), RS1001436503 (6:129862806 T>C), RS1001509450 (6:129849599 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001304_5 | Renal sinus fat | 6.000000e-06 |
| GCST008839_463 | Height | 5.000000e-12 |
| GCST008839_488 | Height | 5.000000e-43 |
| GCST009597_210 | Multiple sclerosis | 2.000000e-07 |
| GCST011742_49 | Triglyceride levels in HIV infection | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004864 | renal sinus adipose tissue measurement |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| archazolid B | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.